search
Advanced Medicine
Trends
- 1
Health outlets are highlighting an mRNA vaccine being developed for melanoma, the deadliest form of skin cancer. The approach uses the same mRNA technology proven in COVID-19 vaccines, training the immune system to recognize and attack tumor cells. WVU Medicine shared the update, and the item is drawing attention as trials of personalized cancer vaccines continue to advance globally.
- 2Study Finds Proliferative Pause Could Help Prevent Brain Metastasis▼Proliferative Pause Reveals Window to Prevent Brain Metastasis
Researchers report that a 'proliferative pause' — a dormant phase cancer cells enter before spreading — may offer a critical window to intervene and stop brain metastasis before it takes hold. The findings, covered by Inside Precision Medicine, suggest targeting cells during this quiet period could prevent secondary brain tumours, a major cause of death in patients with advanced cancers such as breast cancer and melanoma.
- 3Mandatory Ambulatory Specialty Model Advances Despite Physician Opposition▼Mandatory Ambulatory Specialty Model Moves Ahead Despite Medicine’s Concerns
A mandatory ambulatory specialty payment model is moving forward, according to the Texas Medical Association, which notes that the physician community continues to raise concerns about its design and impact on medical practices. Doctors' groups worry the model could constrain how specialists deliver outpatient care, even as regulators proceed with implementation despite calls from medicine to slow down or revise it.
- 4Weill Cornell gets $3M to study HIV's effects on the brain▼Weill Cornell receives $3M to launch research center for HIV’s effects on brain
Weill Cornell Medicine has received a $3 million gift to establish a research center focused on how HIV affects the brain. The center will support research into the neurological impacts of the virus, which can persist in patients even when the infection is controlled by antiretroviral therapy. The funding is intended to advance understanding of HIV-associated neurocognitive disorders and develop new approaches to treatment.
- 5Former Pfizer CSO Bill Sessa Named Chair of Isomab's Scientific Advisory Board▼Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board
Professor Bill Sessa, previously Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The appointment was announced via PR Newswire. It signals Isomab's effort to strengthen its scientific leadership as it advances its development programs, bringing senior pharmaceutical industry experience to the company's advisory structure.
- 6Anthropic joins ARPA-H clinical AI moonshot●Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
Anthropic has joined ARPA-H's clinical AI moonshot program and will host a closed-door event focused on health care applications of artificial intelligence. The partnership signals growing involvement of major AI companies in US government-backed medical research, as health agencies push to bring advanced AI tools into clinical settings.
- 7Scientists refine targeting of cell-surface proteins▼Targeting cell-surface proteins with greater precision
News-Medical reports on advances allowing researchers to target cell-surface proteins with greater precision, a development relevant to drug delivery and therapeutic design. Cell-surface proteins are key entry points for medicines, so improved targeting accuracy could mean more effective treatments with fewer side effects. The report has drawn attention from readers following progress in biotechnology and molecular medicine.
- 8US Army Officer Advances Medical AI Collaboration●LTC Kirkwood Advances Medical AI Collaboration through Engineer and Scientist Exchange Program
Lieutenant Colonel Kirkwood of the Uniformed Services University is advancing collaboration on medical artificial intelligence through the Engineer and Scientist Exchange Program. The initiative connects military researchers with partner-nation scientists to share expertise in AI applications for healthcare and medicine, strengthening international research ties in military medical technology.
- 9Cancer vaccine puts terminal patient into remission▼Exclusive | She was ready to die. Now she’s in remission — cancer vaccines could be the next big thing in medicine
A woman who had been prepared to die has entered remission after receiving an experimental cancer vaccine, in a report highlighting the technology as a possible next major advance in medicine. The case is being presented as evidence that therapeutic vaccines, which train the immune system to attack tumors, could transform cancer treatment.
- 10Aptadir raises €40M to advance demethylating medicines●Aptadir has €40M warchest to advance demethylating medicines
Spanish biotech Aptadir has secured a €40 million funding package to advance its demethylating medicines, a class of therapies targeting epigenetic changes in cancer cells. The company says the new capital will support development of its pipeline of epigenetic drug candidates as it moves toward clinical progress.